Steven Nathan, MD, and Imre Noth, MD, provide their insights into the challenging management of patients with an interstitial lung disease (ILD). They discuss key considerations in the diagnosis and differential diagnosis of an ILD and the evolution in individualized treatment, including palliative care.

Content Areas

  • Definition and epidemiology
  • Pathogenesis
  • Evaluation and diagnosis
  • Nonpharmacologic and pharmacologic treatment
  • Acute exacerbations
  • Palliative care
  • Future directions

Target Audience

This activity was developed for pulmonologists, rheumatologists, and other clinicians who may encounter patients with interstitial lung diseases (ILDs) and/or connective tissue diseases (CTDs).

Faculty

Steven D. Nathan, MD
Steven D. Nathan, MD
Director, Advanced Lung Disease and Lung Transplant Programs
Inova Fairfax Hospital
Fairfax, Virginia
Imre Noth, MD
Imre Noth, MD
Chief of Pulmonary & Critical Care Medicine
Professor of Medicine
University of Virginia School of Medicine
Charlottesville, Virginia
Enter your information to begin.
CME Credit
Available Credit: 1.50 AMA PRA Category 1 Credits™.
1.50 AANP Contact Hours
Opens: October 31, 2018
Expires: October 30, 2019
Target Audience: Pulmonologists
Rheumatologists
Other Health Care Providers
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.